TPTX » Topics » B. Option Grants in Fiscal Year 2004

This excerpt taken from the TPTX DEF 14A filed May 17, 2005.

B.            Option Grants in Fiscal Year 2004

                The following table sets forth certain information with respect to option grants to our Named Executive Officers in 2004. All of the grants were made under the Axonyx 2000 Stock Option Plan. We have not granted any stock appreciation rights.

 
Option Grants in Fiscal Year 2004

Individual Grants Potential Realizable Value at
Assumed Annual Rates of
Stock
Price Appreciation for Option
Term (1)


Name Number of securities
underlying Options
Granted (#)
Percent of total
options granted to
employees in
fiscal year
Exercise or
base price
($/Sh)
Expiration
date
5% ($) 10% ($)

 
 
 
 
 
 
 
Marvin S. Hausman (2)   200,000   57.1%   $ 7.03 12/7/14   $ 884,226   $ 2,240,802  
Gosse B. Bruinsma (3)   100,000   28.6%   $ 7.03 12/7/14   $ 442,113   $ 1,120.401  
S. Colin Neill (4)   50,000   14.3%   $ 7.03   12/7/14   $ 221,056   $ 560,200  
     
  (1)
These amounts represent hypothetical gains that could be achieved for the respective options at the end of the ten year option term. The assumed 5% and 10% rates of compounded stock price appreciation are mandated by rules of the Securities and Exchange Commission and do not represent Axonyx’s estimate of the future market price of the common stock.
     
  (2)
On December 7, 2004, Axonyx granted 200,000 Incentive Stock Options exercisable at $7.03 per share to Marvin S. Hausman, M.D., with 50,000 options vesting on December 7, 2004, 2005, 2006 and 2007.
     
  (3)
On December 7, 2004, Axonyx granted 100,000 Incentive Stock Options exercisable at $7.03 per share to Gosse B. Bruinsma, M.D., with 25,000 options vesting on December 7, 2004, 2005, 2006 and 2007.
     
  (4)
On December 7, 2004 Axonyx granted 50,000 Incentive Stock Options exercisable at $7.03 per share to S. Colin Neill, with 12,500 options vesting on December 7, 2004, 2005, 2006 and 2007.
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki